Published in PLoS One on August 10, 2017
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect (1999) 17.95
Interaction of chlamydiae and host cells in vitro. Microbiol Rev (1991) 8.10
Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses (1994) 6.35
Immunity to murine chlamydial genital infection. Infect Immun (2002) 4.64
Mucosal vaccines: the promise and the challenge. Nat Rev Immunol (2006) 4.41
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol (1995) 3.32
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun (1997) 3.12
Clinical practice. Genital chlamydial infections. N Engl J Med (2003) 2.77
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect Immun (1983) 2.72
Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun (1991) 2.62
Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis (1993) 2.58
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst (2003) 2.58
Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun (1985) 2.54
Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53
Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis (2013) 2.33
Increasing chlamydia positivity in women screened in family planning clinics: do we know why? Sex Transm Dis (2008) 2.33
Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med (1996) 2.30
Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26
A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol (2005) 2.26
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One (2015) 2.26
Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity (2002) 2.17
Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res (1999) 2.17
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci U S A (2011) 2.14
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine (1995) 2.06
Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol (1997) 2.02
Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60. Infect Immun (1992) 1.99
Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity (1998) 1.96
Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis (1987) 1.95
Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun (1991) 1.93
The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis (1996) 1.88
Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis (2010) 1.87
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol (2002) 1.76
Findings from STD screening of adolescents and adults entering corrections facilities: implications for STD control strategies. Sex Transm Dis (2002) 1.76
Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis (2010) 1.74
Type-specific antibodies in human Chlamydia trachomatis infections of the eye. J Immunol (1974) 1.73
Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis (2009) 1.69
Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis (1996) 1.67
Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. J Acquir Immune Defic Syndr (2000) 1.65
Correlation of infecting serovar and local inflammation in genital chlamydial infections. J Infect Dis (1989) 1.65
Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci U S A (2006) 1.63
Immunization against bacterial diseases of the intestine. J Pediatr Gastroenterol Nutr (2000) 1.60
The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis (2008) 1.60
Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology (2007) 1.48
IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol (1999) 1.48
Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology (2002) 1.48
Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis (2010) 1.47
Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis (2003) 1.43
Duration of untreated genital infections with chlamydia trachomatis: a review of the literature. Sex Transm Dis (2000) 1.42
Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen (2006) 1.39
Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures. J Immunol Methods (1999) 1.34
Follicular cervicitis--colposcopic appearances and association with Chlamydia trachomatis. Br J Obstet Gynaecol (1981) 1.28
Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect Immun (1999) 1.25
A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol (2008) 1.20
In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection. J Immunol (2003) 1.14
Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am J Reprod Immunol (1995) 1.13
Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide. Infect Immun (1990) 1.12
Mucosal immune system of the human genital tract. J Infect Dis (1999) 1.10
Characterization of a Chlamydia psittaci DNA binding protein (EUO) synthesized during the early and middle phases of the developmental cycle. Infect Immun (1998) 1.06
Intraepithelial cell neutralization of HIV-1 replication by IgA. J Immunol (2005) 1.05
Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women. AIDS Res Hum Retroviruses (2010) 1.05
Colposcopic and histologic findings in cervical chlamydial infection. Obstet Gynecol (1982) 1.02
IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections. Mucosal Immunol (2014) 1.02
A regulator from Chlamydia trachomatis modulates the activity of RNA polymerase through direct interaction with the beta subunit and the primary sigma subunit. Genes Dev (2009) 1.01
Immunology of the human genital tract. Curr Opin Infect Dis (2003) 0.99
Enzyme-linked immunosorbent assay (ELISA) to detect antibodies in gonorrhea using whole cells. J Clin Pathol (1981) 0.99
Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Natl Acad Sci U S A (2011) 0.97
The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-specific epitopes. Infect Immun (1987) 0.97
Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns. Front Cell Infect Microbiol (2014) 0.97
Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals. AIDS Res Hum Retroviruses (1994) 0.96
Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections. Front Cell Infect Microbiol (2014) 0.95
The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. Best Pract Res Clin Obstet Gynaecol (2002) 0.95
Association of Chlamydia trachomatis Serovar Ia infection with black race in a sexually transmitted diseases clinic patient population in Birmingham, Alabama. Sex Transm Dis (2006) 0.95
Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection. J Infect Dis (2012) 0.94
Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells. Proc Natl Acad Sci U S A (2014) 0.93
Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression. J Acquir Immune Defic Syndr (1993) 0.92
A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci. PLoS One (2012) 0.92
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun (2016) 0.90
Evaluation of the cervical cytobrush sampling technique for the preparation of CD45+ mononuclear cells from the human cervix. J Immunol Methods (2001) 0.87
Isolation of Chlamydia trachomatis and membrane vesicles derived from host and bacteria. J Microbiol Methods (2012) 0.85
Detection of lipopolysaccharide (LPS) and identification of its serotype by an enzyme-linked immunosorbent assay (ELISA) using poly-L-lysine. J Immunol Methods (1992) 0.85
The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin. BMC Immunol (2012) 0.84
Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica. Pathog Dis (2014) 0.83
Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens. Immunol Cell Biol (2014) 0.82
Mycoplasma genitalium infection is associated with microscopic signs of cervical inflammation in liquid cytology specimens. J Clin Microbiol (2014) 0.82
Immunity to Chlamydia trachomatis. J Infect Dis (2013) 0.82
Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections. Immunology (2014) 0.82
Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8. J Immunol (2012) 0.81
Long-term clinical, microbiological, and immunological observations of a volunteer repeatedly infected with Chlamydia trachomatis. J Clin Microbiol (1982) 0.79
Transforming growth factor-beta inhibits the production of IgG, IgM, and IgA in human lymphocyte cultures. Cell Immunol (1992) 0.79
A re-evaluation of the role of B cells in protective immunity to Chlamydia infection. Immunol Lett (2015) 0.78
Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2014) 0.76
Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection. J Infect Dis (2017) 0.76
Effect of glutaraldehyde-fixation on the immunogenicity, particle stability and antigenic reactivity of alfalfa mosaic virus, and the specificity of elicited antibodies. J Virol Methods (1991) 0.76